Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Carbohydrate doai
Reissue Patent
2006-06-27
2006-06-27
Peselev, Elli (Department: 1623)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Carbohydrate doai
C424S464000, C424S465000, C424S474000, C424S480000, C424S482000, C514S960000, C536S007200, C536S007400
Reissue Patent
active
RE039149
ABSTRACT:
An oral dosage form of azithromycin which does not exhibit an adverse food effect; Specific azithromycin oral dosage forms including tablets, powders for oral suspensions and unit dose packets; Methods of treating microbial infections with the dosage forms; And therapeutic packages containing the dosage forms.
REFERENCES:
patent: 4382085 (1983-05-01), Sciavolino et al.
patent: 4474768 (1984-10-01), Bright
patent: 4517359 (1985-05-01), Kobrehel et al.
patent: 4963531 (1990-10-01), Remington
patent: 5250518 (1993-10-01), Kobrehel et al.
patent: 5350839 (1994-09-01), Asaka et al.
patent: 5633006 (1997-05-01), Catania et al.
patent: 6068859 (2000-05-01), Curatolo et al.
patent: 6268489 (2001-07-01), Allen et al.
patent: 0307128 (1989-03-01), None
patent: 0298650 (1992-02-01), None
patent: 0307128 (1992-04-01), None
patent: 0582396 (1994-02-01), None
patent: 0582396 (2001-01-01), None
patent: WO 9509601 (1995-04-01), None
CA Abstracts: vol. 120:38194a; (1994).
Zithromax (Trademark of Pfizer, Inc.) Capsules Package Insert for azithromycin capsule dosage form sold commercially in U.S.
Curatolo, et al.,Perforated Coated Tablets for Controlled Release of Drugs at a Constant Rate, Journal of Pharmaceutical Sciences,vol. 77, No. 4, pp. 322-324, (1988).
Welling, P. G., et. al.,Bioavailability of Erythromycin Stearate: Influence of Food and Fluid Volume, Journal of Pharmaceutical Sciences,vol. 67, No. 6, pp. 764-766, (1978).
Welling, P. G., et. al.,Plasma Levels following Single and Repeated Doses of Erythromycin Estolate and Erythromycin Stearate, Journal of Pharmaceutical Sciences,vol. 68, No. 2, pp. 150-155, (1979).
Malmborg, A.,Absorption of erthromycin stearate after oral administration, Curr. Med. Res. Opin.,vol. 5, (Suppl. 2)., pp. 15-18, (1978).
Drew, R. H., et. al.Azithromycin—Spectrum of Activity, Pharmacokinetics, and Clinical Applications, Pharmacotheraphy,vol. 12, No. 3, pp. 161-173, (1992).
Chu, S., et. al.,Drug-Food Interaction Potential of Clarithromycin, a New Macrolide Antimicrobial, J. Clin. Pharmacol.,vol. 32, pp. 32-36, (1992).
Hopkins, S.,Clinical Toleration and Safety of Azithromycin, The American Journal of Medicine,vol. 91 (Suppl. 3A), pp. 40S-45S, (1991).
Toothaker, R. D., et al.,The Effect of Food on Drug Bioavailability, Ann. Rev. Pharmacol, Toxicol.,vol. 20, pp. 173-199, (1980).
Russell, T. L., et al.,Upper Gastrointestinal pH in Seventy-nine Healthy, Elderly North American Men and Women, Pharmaceutical Research,vol. 10, No. 2, pp. 187-196, (1993).
Zithromax (Trademark of Pfizer Inc.) Tablet and Powder for Oral Suspension Package Insert for azithromycin tablets and powder for oral suspension dosage forms sold commercially in Italy (1992).
Documents relating to the European Patent Office Opposition proceedings regarding EU Patent No. 0 679 400 (Opposition file).
Curatolo William J.
Foulds George H.
Friedman Hylar L.
Benson Gregg C.
Creagan B. Timothy
Liu Lance Y.
Peselev Elli
Pfizer Inc.
LandOfFree
Method of administering azithromycin does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method of administering azithromycin, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of administering azithromycin will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3657742